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In most countries, although uptake of childhood vaccines is generally high, pockets of under-
vaccination pose a continued threat to individual protection and population immunity, with 
some of these pockets the foci of recent disease outbreaks [1,2]. Vaccination safety scares 
have led to long-term reductions in coverage, as evidenced by reduced coverage of MMR 
vaccine post the suggested association with autism in many countries [3, 4]. Increasingly, 
experts and commentators have used the term ‘vaccine hesitancy’ to explain sub-optimal 
vaccination coverage, regardless of the contextual contributory causes [5].  We contend that 
using the term ‘vaccine hesitancy’ to explain all partial or non-vaccination is inaccurate, and 
risks generating solutions that are a poor match for the problem in a particular community or 
population. Here, we propose more precision in the use of the term ‘vaccine hesitancy,’ and 
its delineation from factors related to access and pragmatics. Only with a clear distinction 
between these determinants can we develop appropriate policies and strategies targeted to 
the specific drivers of lower-than-desired vaccination coverage in each population.  
2 
 
Hesitancy is defined in the Oxford English Dictionary as “The quality or condition of hesitating; 
indecision, vacillation; an instance of this.” To hesitate is to “hold back in doubt or indecision; 
to show, or speak with, indecision; to find difficulty in deciding; to scruple.” These definitions 
portray hesitancy as a psychological state which may delay action or result in inaction. The 
terms “hesitant, hesitate or hesitancy” were first applied to vaccination in 1994 to describe 
physicians’ reluctance to prescribe a vaccine. From 2004, journal articles began to relate 
hesitancy to parents or adult vaccination recipients, reaching a peak in 2015 with 50 articles 
indexed in Medline using the term.  
The term “hesitancy” is now widely used in public commentary about vaccination coverage, 
with three problematic patterns emerging: (1) ‘Vaccine hesitancy’ is represented as a 
behaviour, even though it is a psychological state; (2) the label ‘hesitancy’ is applied to non-
vaccination, when in fact some non-vaccinators are forthright in their refusal, and may never 
have been hesitant and (3) ‘hesitancy’ is used as the explanation for under-vaccination in a 
population when, in fact, the causes are related to pragmatics, access, or the failure of 
services or policies. 
The WHO SAGE vaccine hesitancy working group (which was constituted to address the 
emerging phenomenon in November 2011) grappled with defining vaccine hesitancy. It rested 
with a behaviourally-related definition: “a delay in acceptance or refusal of vaccines despite 
availability of vaccination services”. The group rightly noted that hesitancy is a complex and 
context specific phenomenon, varying across time, place and vaccines. However, its report 
went on to conclude that vaccine hesitancy is influenced by factors such as confidence (do 
not trust vaccine or provider), complacency (do not perceive a need for a vaccine, do not 
value vaccination), and convenience (access to vaccines)” [6]. Additionally, they considered 
that while some parents might still value and have access to vaccines, vaccination may be a 
low priority due to domestic pressures or busy lives.   
We believe that adding the concept of ‘convenience’ (and its related notion of parental 
prioritisation) to a definition of hesitancy is problematic. It bundles together concepts relating 
to individuals’ decisions (selecting out or refusing vaccines) with individual and system-level 
factors that may contribute to difficulties accessing vaccines. Understandably, the WHO 
report sought to keep service-related factors on the global agenda, ensuring that countries 
and services continued to be accountable for their role in ensuring high vaccination uptake. 
However, the settled definition perpetuates terminological imprecision. This imprecision 
could lead to the development of one-solution policies and interventions designed to 
overcome ‘vaccine hesitancy’ that fail to account for the range of causes of sub-optimal 
vaccination.  
Notably, the problematic usage of the term ‘vaccine hesitancy’ in the media and medical 
literature does not give sufficient emphasis to the social determinants of vaccination. These 
can impede access to existing resources, and are arguably the largest contributor to under-
3 
 
vaccination. For example, a community might have low vaccination rates, assumed to be due 
to parents’ actively refusing vaccination. In response, an agency might implement a campaign 
to address ‘hesitancy,’ only to find that the main barriers were actually inflexible and 
inadequate primary care services, work-place policies minimising time-off for parents, or 
missed opportunities.   
Indeed, many studies find that access barriers are a significant reason for children not being 
up to date with their vaccinations [7, 8, 9]. These children are more likely to be economically 
disadvantaged, belong to larger families, and face practical or logistical challenges to access 
[8, 9, 10]. Access barriers apply at both an individual and a “system” level and are ripe for 
solutions to minimise them (such as lack of transport or money) by providing accessible, 
responsive services. Interventions such as hospital-based opportunistic immunisation [11], 
domiciliary immunisation [12], following up and reminding parents [13] about due 
immunisations are effective, and continue to be important in improving coverage. Here, 
governments must take responsibility to maximise the opportunities to vaccinate. However, 
such interventions do not address the (distinct) phenomenon of ‘vaccine hesitancy’ as we 
propose it should be defined. 
The term ‘vaccine hesitancy’ should be applied to those parents whose conscious 
deliberations demonstrate something akin to indecision. However, the hesitancy concept will 
still not capture all who do not accept vaccines, since some parents may be decisive outright 
‘rejectors’ of vaccines. Additionally, not all parents who have concerns refuse vaccines; in fact 
the vast majority of parents accept all vaccines on schedule despite some degree of concern. 
Hence we concur with the WHO working group figure, which puts hesitancy on a spectrum 
from full and partial to no vaccination [14].  
Since vaccine uptake is affected by both acceptance and the logistical or opportunity-related 
factors we described earlier, coverage figures cannot be a good indicator of vaccine 
‘hesitancy’. Coverage (or lack thereof) gives no indication of any hesitancy on the pathway to 
full immunisation. Rather, purpose-built instruments are the only way to measure vaccine 
hesitancy [15, 16, 17]. Instruments developed (or under development) have focused on 
attitudes, safety, efficacy and behavioural constructs, such as trust, rather than access issues, 
which is entirely appropriate. Ongoing development and validation of these instruments 
across different settings will be important. Our engagement with attitudinal factors affecting 
uptake may also be enhanced by the use of existing terms that have been psychometrically 
validated, such as “decisional conflict,” which refers to a state of uncertainty about a course 
of action. Decisional conflict is an internationally accepted construct with a validated scale 
where certain scores correlate with action. Importantly, the measure is sensitive to 
vaccination-related interventions [18].   
There are other ways to identify the determinants of vaccination that can potentially navigate 
the access and acceptance dichotomy more effectively, especially when working towards 
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interventions to increase uptake. After reviewing studies, Thomson et al [19] identified five 
fundamental causes of under vaccination: challenges to Access, Affordability, Awareness, 
Acceptance and Activation, a taxonomy referred to as the “5 As”. These domains capture 
most determinants of vaccine uptake. Future research could validate their 
comprehensiveness, assess their relative contributions to under vaccination and evaluate 
their utility in informing the development of evidence based solutions to low coverage.   
There is a need to develop and evaluate solutions, tailored to the challenges of vaccine 
hesitancy, which are distinct from those needed for logistical problems. Finding and agreeing 
upon terms to clearly distinguish between vaccine hesitancy and the other determinants of 
uptake is an important start. We would suggest under-vaccinated as the over-arching term 
capturing both those who are unvaccinated and partially vaccinated for any reason. Reasons 
for under-vaccination could then be further expanded into a set of constructs with good 
content and construct validity. Each needs development of different interventions to improve 
uptake. Only an accurate terminology can give us a clear idea of where the problem lies, allow 
us to assess its scale, and then focus our attention accordingly. This way, our interventions 
have the very best chance of success in making vaccines available to those who want them, 
and helping those who are uncertain about their vaccination decision. 
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